BSE Live
Dec 31, 16:01Prev. Close
72.60
Open Price
72.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 31, 15:40Prev. Close
72.44
Open Price
72.44
Bid Price (Qty.)
73.32 (20)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Bal Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 5.73 | 12.11 | 8.55 | 12.06 | 9.80 | |
| Net CashFlow From Operating Activities | 20.31 | 28.95 | 5.07 | 31.48 | 10.24 | |
| Net Cash Used In Investing Activities | -14.90 | -18.43 | -22.08 | -13.43 | -6.66 | |
| Net Cash Used From Financing Activities | -7.83 | -7.71 | 17.43 | -18.13 | -3.36 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -2.42 | 2.81 | 0.42 | -0.08 | 0.21 | |
| Cash And Cash Equivalents Begin of Year | 4.06 | 1.23 | 0.81 | 0.89 | 0.68 | |
| Cash And Cash Equivalents End Of Year | 1.64 | 4.04 | 1.23 | 0.81 | 0.89 |
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y